Mechanism and regulation of DNA double-strand break repair
DNA双链断裂修复机制及调控
基本信息
- 批准号:10407594
- 负责人:
- 金额:$ 61.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesBiological AssayBiological ModelsCell CycleCellsCellular Metabolic ProcessChemotherapy and/or radiationChromatin StructureChromosomesComplexCoupledDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair GeneDNA biosynthesisDNA damage checkpointDNA replication forkDefectDevelopmentDiseaseDouble Strand Break RepairEventExcisionGeneticGenomic InstabilityGoalsHumanImmunologicsInvestigationKnowledgeLaboratoriesLeadLengthLesionMalignant NeoplasmsMeasuresNeurologicNonhomologous DNA End JoiningNormal CellPathway interactionsPhosphotransferasesPredispositionProcessRegulationResearchResistanceSaccharomyces cerevisiaeSiteToxic effectYeastschromosome losscytotoxicgenome integrityhomologous recombinationinsightnext generation sequencingnovel therapeuticspractical applicationprogramsrecombinational repairrecruitrepairedtargeted treatmenttelomere
项目摘要
Chromosomal double strand breaks (DSBs) are cytotoxic lesions that occur spontaneously during normal cell
metabolism or following treatment of cells with DNA-damaging agents. If unrepaired or repaired inappropriately,
DSBs can lead to profoundly detrimental events, such as chromosome loss, deletions, duplications or
translocations. Defects in the repair of DSBs cause genomic instability, manifested as immunological,
development or neurological defects, and predisposition to cancer. The toxicity of DSBs is exploited for
radiation and chemotherapy, as well as targeted therapies directed against specific DNA repair proteins. Thus
understanding the mechanisms of DSB repair is of fundamental importance and has practical application for
development of new therapeutics and uncovering pathways to resistance. Typically, cells repair DSBs by either
homologous recombination (HR) or non-homologous end joining (NHEJ). HR employs extensive homology and
templated DNA synthesis to restore the broken chromosome and is considered to be an error-free process.
NHEJ directly ligates DSB ends, a mechanism that is potentially error prone due to small deletions or
insertions at the junctions. The choice between these two pathways is governed by the cell cycle, which
regulates an early step in HR, namely, 5'-3' resection of DSBs. The overall goal of our research program is to
decipher the mechanisms of homology-dependent DSB repair, using the yeast Saccharomyces cerevisiae as a
model system. The first part of our program builds on our previous studies showing that the conserved Mre11-
Rad50-Xrs2 (MRX) complex initiates 5'-3' resection. Specifically, we will use next-generation sequencing to
identify the sites of MRX nicking, determine how chromatin structure influences nick site selection and
measure the length of resection tracts in cells undergoing HR repair. In addition to controlling end resection,
MRX promotes NHEJ, tethers DSB ends and recruits the Tel1ATM kinase to DSBs to activate the DNA damage
checkpoint. We will determine the contribution of these diverse functions to genome integrity using specific
alleles of MRX components coupled to assays measuring gross chromosome rearrangements. DSBs that arise
by replication fork collapse or by erosion of uncapped telomeres have only one free end and are repaired by
strand invasion into a homologous duplex DNA followed by replication to the chromosome end (break-induced
replication, BIR). The second part of our research program utilizes physical and genetic assays developed in
my laboratory to address the mechanism and fidelity of DNA synthesis by BIR.
染色体双链断裂(DSB)是在正常细胞周期中自发发生的细胞毒性损伤。
在某些实施方案中,细胞可以通过代谢或在用DNA损伤剂处理细胞之后进行。如果未经修理或修理不当,
DSB可导致严重的有害事件,如染色体丢失、缺失、复制或突变。
易位DSB修复缺陷导致基因组不稳定,表现为免疫学,
发育或神经缺陷,以及癌症易感性。DSB的毒性被用于
放疗和化疗,以及针对特定DNA修复蛋白的靶向治疗。因此
了解DSB修复的机制具有根本的重要性,并具有实际应用,
开发新的治疗方法和发现耐药途径。通常,细胞通过以下方式修复DSB:
同源重组(HR)或非同源末端连接(NHEJ)。HR采用广泛的同源性,
模板化DNA合成以恢复断裂的染色体,并且被认为是无错误的过程。
NHEJ直接连接DSB末端,这是一种由于小的缺失或缺失而可能容易出错的机制。
在连接处插入。这两种途径之间的选择是由细胞周期,
调节HR的早期步骤,即DSB的5 '-3'切除。我们研究计划的总体目标是
利用酿酒酵母作为一种新的基因工程工具,
模型系统。我们计划的第一部分建立在我们以前的研究基础上,表明保守的Mre 11-
Rad 50-Xrs 2(MRX)复合物启动5 '-3'切除。具体来说,我们将使用下一代测序技术,
确定MRX切口位点,确定染色质结构如何影响切口位点选择,
测量进行HR修复的细胞中切除道的长度。除了控制末端切除,
MRX促进NHEJ,束缚DSB末端并将Tel 1ATM激酶募集至DSB以激活DNA损伤
检查站我们将确定这些不同的功能,基因组完整性的贡献,使用特定的
MRX组分的等位基因偶联至测量总染色体重排的测定。出现的争端解决机构
通过复制叉崩溃或通过无帽端粒的侵蚀,只有一个自由端,
链侵入同源双链DNA,随后复制到染色体末端(断裂诱导
复制,BIR)。我们的研究计划的第二部分利用物理和遗传分析,
我的实验室,以解决机制和保真度的DNA合成的BIR。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lorraine S Symington其他文献
Lorraine S Symington的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lorraine S Symington', 18)}}的其他基金
Rad52-dependent recombination in response to replication stress
响应复制压力的 Rad52 依赖性重组
- 批准号:
9894801 - 财政年份:2019
- 资助金额:
$ 61.68万 - 项目类别:
Mechanism and regulation of DNA double-strand break repair
DNA双链断裂修复机制及调控
- 批准号:
10623591 - 财政年份:2018
- 资助金额:
$ 61.68万 - 项目类别:
Mechanism and regulation of DNA double-strand break repair
DNA双链断裂修复机制及调控
- 批准号:
10174946 - 财政年份:2018
- 资助金额:
$ 61.68万 - 项目类别:
Break-induced replication and genome rearrangements
断裂诱导的复制和基因组重排
- 批准号:
8881215 - 财政年份:2010
- 资助金额:
$ 61.68万 - 项目类别:
Break-induced replication and genome rearrangements
断裂诱导的复制和基因组重排
- 批准号:
8293148 - 财政年份:2010
- 资助金额:
$ 61.68万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 61.68万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 61.68万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 61.68万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 61.68万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 61.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 61.68万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 61.68万 - 项目类别: